Global /India /Healthcare /Drug Manufacturers - General /NECLIFE
chevron_leftBack
Nectar Lifesciences Ltd. logo

Nectar Lifesciences Ltd.

NECLIFE
NSE: NECLIFE Delayed
12.41INR -1.6%
0.1314 USD
As of 20 June 2026, Nectar Lifesciences Ltd. has a market cap of $25.95M USD, ranking #35272 globally and #2442 in India. It ranks #3190 in the Healthcare sector, and #1077 in the Drug Manufacturers - General industry.
Global Rank
35272
Country Rank
2442
Sector Rank
3190
Industry Rank
1077
Key Stats
Market Cap
$25.95MUSD
2.45B INR
Enterprise Value
$73.86MUSD
6.97B INR
Revenue (TTM)
$176.97MUSD
16.7B INR
EBITDA (TTM)
-$2.84MUSD
-267.85M INR
Net Income (TTM)
-$37.62MUSD
-3.55B INR
EBITDA Margin
-1.6%
Profit Margin
-21%
PS Ratio
0.1
PB Ratio
0.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Amit Chadah open_in_new
Employees
1,786
Founded
1995
Website
neclife.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.6% 3.6% 29% -9.1% -16% -43%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
NECLIFE
Nectar Lifesciences Ltd
ISIN: INE023H01027
Shares Out.:
194.261M1 Shares Float: 103.459M2
TV:
SA:
YF:
GF:
BA:
MS:
12.41 INR
Bombay Stock Exchange
MIC: XBOM
532649 (NECLIFE)
Nectar Lifesciences Ltd
ISIN: INE023H01027
TV:
SA:
YF:
GF:
BA:
MS:
12.58 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Nectar Lifesciences Ltd.

Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also provides contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company offers menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
174K%
39.1
DIVISLAB
$18.38B
1.73T INR
71K%
70.0
$15.17B
1.43T INR
58K%
63.0
$11.73B
1.11T INR
45K%
19.6
MANKIND
$9.87B
931.67B INR
38K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
37K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
3M%
38.1
JNJ
$547.28B
2M%
26.4
ABBV
$360.63B
1M%
97.4
$318.3B
256.25B CHF
1M%
19.9
AZN
$284.64B
215.59B GBP
1M%
27.6
MRK
$274.03B
1M%
15.1
chevron_leftBack